Seiji IsonishiDepartment of Obstetrics and GynecologyThe Jikei University School of MedicineMinato-ku, Tokyo, Japan  Yoshihiro Kikuchi Department of GynecologyOhki Memorial Kikuchi Cancer Clinic for WomenTokorozawa, Japan

• 1 Cancer Stem Cells in gynecologic cancer.- 2 Patient-derived xenograft models in gynaecological malignancies.- 3 Cancer genomic profiling of gynecological malignancies by Todai OncoPanel, a twin DNA and RNA panel.- 4 Investigating the molecular carcinogenesis of ovarian high-grade serous cancer.- 5 The role of G protein-coupled receptor signaling in gynecologic malignancy.- 6 Tailor-made therapy according genetic alteration in epithelial ovarian cancers.- 7 Signaling and drug resistance.- 8 Molecular analysis in endometrial carcinoma.- 9 Molecular Landscape in Ovarian Clear Cell Carcinoma.- 10 Molecular pathology and clinicopathological significance of endometrial carcinoma.- 11 Novel approach for therapeutics of cervical cancer based on HPV-associated carcinogenesis at the cervix.- 12 Hereditary gynecological malignancy and molecular features.

Seiji IsonishiDepartment of Obstetrics and GynecologyThe Jikei University School of MedicineMinato-ku, Tokyo, Japan  Yoshihiro Kikuchi Department of GynecologyOhki Memorial Kikuchi Cancer Clinic for WomenTokorozawa, Japan

• 1 Cancer Stem Cells in gynecologic cancer.- 2 Patient-derived xenograft models in gynaecological malignancies.- 3 Cancer genomic profiling of gynecological malignancies by Todai OncoPanel, a twin DNA and RNA panel.- 4 Investigating the molecular carcinogenesis of ovarian high-grade serous cancer.- 5 The role of G protein-coupled receptor signaling in gynecologic malignancy.- 6 Tailor-made therapy according genetic alteration in epithelial ovarian cancers.- 7 Signaling and drug resistance.- 8 Molecular analysis in endometrial carcinoma.- 9 Molecular Landscape in Ovarian Clear Cell Carcinoma.- 10 Molecular pathology and clinicopathological significance of endometrial carcinoma.- 11 Novel approach for therapeutics of cervical cancer based on HPV-associated carcinogenesis at the cervix.- 12 Hereditary gynecological malignancy and molecular features.

Seiji IsonishiDepartment of Obstetrics and GynecologyThe Jikei University School of MedicineMinato-ku, Tokyo, Japan  Yoshihiro Kikuchi Department of GynecologyOhki Memorial Kikuchi Cancer Clinic for WomenTokorozawa, Japan

• 1 Cancer Stem Cells in gynecologic cancer.- 2 Patient-derived xenograft models in gynaecological malignancies.- 3 Cancer genomic profiling of gynecological malignancies by Todai OncoPanel, a twin DNA and RNA panel.- 4 Investigating the molecular carcinogenesis of ovarian high-grade serous cancer.- 5 The role of G protein-coupled receptor signaling in gynecologic malignancy.- 6 Tailor-made therapy according genetic alteration in epithelial ovarian cancers.- 7 Signaling and drug resistance.- 8 Molecular analysis in endometrial carcinoma.- 9 Molecular Landscape in Ovarian Clear Cell Carcinoma.- 10 Molecular pathology and clinicopathological significance of endometrial carcinoma.- 11 Novel approach for therapeutics of cervical cancer based on HPV-associated carcinogenesis at the cervix.- 12 Hereditary gynecological malignancy and molecular features.